Prevnar 20

Wyeth Pharmaceutical Division of Wyeth Holdings LLC🇺🇸 United States

FDA Page

Effective Date: Jul 24, 2026
Approval ID: d4e2cf51-e6a8-4103-bb1d-6120c6474ff8
Products: 1 registered
Version: 12

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PREVNAR 20 safely and effectively. See full prescribing information for PREVNAR 20. PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine), suspension for intramuscular injection Initial U.S. Approval: 2021

Quick Stats

Total Products1

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.